Evaluation of the Performance and Safety of VACUSERA® PRP Tubes in the Preparation of Autologous Platelet-Rich Plasma

INCLUSION CRITERIA Male or female volunteers between the ages of 18 and 60, as defined in the target population during screening, Body Mass Index (BMI) between 18 and 32 during screening, No pregnancy or risk of pregnancy for women, Willing to participate and provide written informed consent and comply with the study restrictions, Must not have participated in any clinical trial within 2 months prior to the start of the study, Must be able to communicate with the researcher or authorized personnel. EXCLUSION CRITERIA Platelet dysfunction syndrome, Critical thrombocytopenia, Hemodynamic instability, Septicemia, Local infection at the site of the procedure, Autoimmune diseases, History of chronic infections, Chronic liver pathology, Patients receiving anticoagulant/antiplatelet therapy, Use of NSAIDs (except for paracetamol) in the last 7-10 days, History of alcohol and/or drug addiction, Corticosteroid use, Fever or illness in the past week, Cancer (especially blood and bone cancers), Hemoglobin (HGB) levels below 10 g/dl or above 16.5 g/dl in men and 16 g/dl in women, Platelet count below 105/μl, Those under immunosuppressive therapy, Any condition or disease detected during the medical interview/physical examination that, in the opinion of the researcher or designated personnel, would make the volunteer unsuitable for the study, put them at unnecessary risk, or interfere with the volunteer's ability to complete the study, Clinically significant devi…